The fate of the enhanced Affordable Care Act premium tax credits — initially bolstered during the pandemic — is still unclear ...
Pfizer is buying its way back into the obesity-drug game after fighting off a rival bid from Novo Nordisk to buy Metsera, ...
You cannot know the power of an investment unless you see the returns. Many think of dividend stocks as a way of generating ...
Discover why Pfizer Inc. is rated a Strong Buy with 33% upside, robust dividends, and growth prospects ahead. Click for my updated look at PFE stock.
South Korea has signed a deal with Pfizer Inc (PFE.N) to buy 30 million doses of COVID-19 vaccine for use in 2022, Korea ...
Pfizer Inc said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.
A second magnificent ultra-high-yield dividend stock that's begging to be bought in November is pharmaceutical titan Pfizer ( ...
President Donald Trump has received updated flu and COVID-19 booster shots in preparation for upcoming travel, the president’s physician announced Oct. 10. Sean P. Barbabella, a U.S. Navy captain, ...
Pfizer saw U.S. Comirnaty sales drop to $870 million in the recently completed third quarter from $1.16 billion in the same ...
Shares of Pfizer Inc. gave up ground in early Tuesday trading, after the drug giant reported a decline in revenue, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results